| Date/Time | Galaxy Theater | Discovery Hall | Universe Arena | Supernova Stage |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 08:50-09:00 | Opening Remark | |||
| 09:00-10:15 | Joint Session 01 (Asia Session) New Era of MPN Treatment | Scientific Session 01 Novel Managements Tools for Hemophilia | Scientific Session 02 ALL 2026: Shifting Standards and Emerging Innovations | Education Session 01 FOCUS ON: Indolent B-cell Lymphomas |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 01 Leukemic Stem Cells in 2026: Hierarchies, Heterogeneity, and Therapeutic Resistance | |||
| 11:15-12:00 | Presidential Symposium Targeted Treatment of Aggressive B-cell Lymphomas | |||
| 12:00-12:15 | Break | |||
| 12:15-13:05 | Satellite Symposium 01 | Satellite Symposium 02 | Satellite Symposium 03 | Satellite Symposium 04 |
| 13:05-13:45 | Poster Viewing 1 (Walker Hall, 1F) | |||
| 13:45-13:55 | Break | |||
| 13:55-15:10 | Oral Presentation 01 | Oral Presentation 02 | Oral Presentation 03 | Oral Presentation 04 |
| 15:10-15:25 | Break | |||
| 15:25-16:40 | Joint Session 02 (MOU Session) The Present and Future of Bone Marrow Failure Syndrome in Asia | Scientific Session 03 Geriatric Hematology | Scientific Session 04 Next-Generation Cell Therapies: In Vivo CAR Engineering, Myeloid Modulation, and Beyond | Education Session 02 Recent Advances in Acute Leukemia |
| 16:40-16:55 | Break | |||
| 16:55-18:10 | Scientific Session 05 MDS: Perspectives from Multiple Viewpoints | Scientific Session 06 Focus on Telomeres in Hematology | Scientific Session 07 Advancing Immunotherapy in Multiple Myeloma: Mechanisms and Next-Generation Strategies | Education Session 03 Integrated Laboratory Perspectives in Hematologic Malignancies: From Initial Workup to Transplantation KOR |
| 18:45~ | Welcome Reception (Aston House) | |||
| Date/Time | Galaxy Theater | Discovery Hall | Universe Arena | Supernova Stage |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 09:00-10:15 | Joint Session 03 (ASH-KSH) Emerging Therapeutic Landscape for Unfit AML | Scientific Session 08 Microbiome-Driven Precision Medicine in Hematology | Scientific Session 09 Future of Immunotherapy in DLBCL | Education Session 04 Understanding Anemia KOR |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 02 The Present and Future of Hematopoietic Stem Cell Gene Therapies | |||
| 11:15-12:00 | Poster Viewing 2 (Walker Hall, 1F) | |||
| 12:00-12:15 | Break | |||
| 12:15-13:05 | Satellite Symposium 05 | Satellite Symposium 06 | Satellite Symposium 07 | Satellite Symposium 08 |
| 13:05-13:35 | Break | |||
| 13:35-14:50 | Oral Presentation 05 | Oral Presentation 06 | Oral Presentation 07 | Oral Presentation 08 |
| 14:50-15:05 | Break | |||
| 15:05-16:20 | Joint Session 04 (EHA-KSH) Cell Therapy & Transplant | Scientific Session 10 Pediatric Malignancies: From Patients to Survivors | Scientific Session 11 Transforming the Therapeutic Landscape of AML: From Biology to Targeted Therapies | Education Session 05 Big Data and AI in Hematology Research KOR |
| 16:20-16:35 | Break | |||
| 16:35-17:50 | Scientific Session 12 Expanding Therapeutic Horizons in ITP and TTP | Scientific Session 13 Other Plasma Cell Disorders: From Diagnosis to Mechanistic Insights | Education Session 06 Toxicity Masterclass: Managing CRS, Cytopenia, and Infections in T Cell Engaging Therapies KOR | |
| 18:30~ | Gala Dinner | |||
| Date/Time | Galaxy Theater | Discovery Hall | Universe Arena | Supernova Stage |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 07:30-08:00 | KSH Business Meeting | |||
| 08:00-08:30 | Young Investigator Award Presentation | |||
| 08:30-09:00 | ||||
| 09:00-10:15 | Joint Session 05 (Asia Session) Lymphoma | Scientific Session 14 Germline Variants and Hematologic Malignancies: Current Understanding and Clinical Implication | Scientific Session 15 Exploring the Map of CML: Beyond BCR::ABL1 | Education Session 07 Preventive and Supportive Approaches in Hematologic Malignancies KOR |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 03 High-risk Multiple Myeloma in 2026: Early Intervention, MRD-driven Therapy, and Beyond | |||
| 11:15-11:30 | Break | |||
| 11:30-12:00 | Closing Ceremony | |||
| 12:00-12:30 | KSH General Assembly | |||